Patent De-Risking: Strategies for Patent Infringement Risk Avoidance

By Contist AI

Patent infringement litigation is among the most expensive categories of commercial dispute in the United States. The median cost to defend a single patent suit through trial and appeal runs from roughly $500,000 when less than $1 million is at stake to over $4 million when more than $25 million is at risk.^[1]1AIPLA Report of the Economic Survey (2023). Median patent litigation costs run from roughly $500,000 (less than $1M at risk) to over $4 million (more than $25M at risk), inclusive of pre-trial, trial, post-trial, and appeal. Available at aipla.org. And the threat surface is expanding: non-practicing entities now account for 55.4% of all U.S. patent lawsuits, up from 51.8% in 2024 — and in absolute terms, NPE filings rose 21.6% year-over-year while total patent case filings increased 12%.^[2]2Unified Patents, "Patent Dispute Report: 2025 in Review" (Jan. 2026). NPE share of U.S. patent lawsuits rose to 55.4% in 2025 (up from 51.8% in 2024); in absolute terms, NPE district court filings increased 21.6% year-over-year, while total patent filings rose 12%. Available at unifiedpatents.com.

Most companies know they need to manage patent infringement risk. The standard playbook — conduct a freedom-to-operate search before launch, secure opinions of counsel where exposure is clear, take a license when the arithmetic favors it — has been the default for decades. But the playbook is built around a structural assumption that does not hold: that patent risk is a point-in-time question answerable from the face of the claims.

It is not. Patent risk is dynamic, multi-layered, and — critically — shaped by prosecution history that most risk-assessment workflows never touch.

The standard playbook and its structural gap

Freedom-to-operate analysis is the right starting point. An FTO search identifies patents whose claims plausibly cover a product, maps claim elements to product features, and produces an opinion on infringement risk. Done well, it is rigorous, jurisdiction-specific, and commercially valuable.

But an FTO search is a snapshot. It answers "is there a patent that appears to cover this product today?" It does not answer several questions that determine whether the risk is real:

How will these claims be construed? Claim construction under Markman is a question of law for the court.^[3]3Markman v. Westview Instruments, Inc., 517 U.S. 370 (1996) (holding that claim construction is a matter of law for the court). The same claim language can be construed broadly or narrowly depending on the specification and prosecution history. An FTO that reads claims at face value — without analyzing the prosecution record — is assessing risk against a claim scope the patentee may not actually possess.

What scope was surrendered during prosecution? Under Festo, any narrowing amendment made for reasons related to patentability creates a presumption that the patentee surrendered equivalents coverage for the particular element that was amended — as to equivalents encompassed by the territory between the original and amended claim language.^[4]4Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., 535 U.S. 722 (2002) (establishing the flexible-bar approach: narrowing amendments create a presumption of surrender, rebuttable on three grounds). That presumption directly narrows the patent's enforceable reach — and an FTO that does not account for it will overestimate risk on some patents and underestimate it on others.

Will the doctrine of equivalents reach our design-around? Under Graver Tank, a product that avoids literal infringement may still infringe if each element performs substantially the same function, in substantially the same way, to achieve substantially the same result.^[5]5Graver Tank & Mfg. Co. v. Linde Air Products Co., 339 U.S. 605 (1950) (establishing the doctrine of equivalents and the function-way-result test). But prosecution history estoppel limits the doctrine's reach. The estoppel map is drawn by the prosecution record — and it is invisible from the face of the claims.

What happens when new patents issue? An FTO conducted in Q1 does not account for patents published in Q2. Continuation applications — with claims drafted after seeing a competitor's product on the market — are a well-documented source of infringement assertions. The patent landscape is not static. An FTO is.

The gap is not in execution. The gap is structural: the problem an FTO addresses is narrower than the problem the business faces.

Patent de-risking is not one task — it is a continuous program

What separates companies that manage patent risk well from those that find themselves in serial litigation is not the quality of any single FTO opinion. It is whether the organization treats patent risk as a continuous intelligence problem or as a gate at product launch.

The distinction matters because patent infringement risk has at least four dimensions, each requiring a different analytical frame.

Literal infringement risk — do the product's features fall within the literal scope of an asserted claim? This is the FTO question, and it is the most tractable.

Equivalents risk — does the product infringe under the doctrine of equivalents, and is that equivalents argument barred by prosecution history estoppel? This requires reading the prosecution record, not just the claims.

Validity risk — are the asserted claims themselves valid? An invalid claim cannot be infringed. The tools for challenging validity — inter partes review at the PTAB, EPO opposition, ex parte reexamination — are powerful when the prior art is strong. The PTAB alone invalidated approximately 70% of all challenged claims through 2024 in cases reaching a final written decision.^[6]6IPWatchdog, "The PTAB's 70% All-Claims Invalidation Rate Continues to Be a Source of Concern" (Jan. 2025). Available at ipwatchdog.com.

Portfolio risk — where across the product line is infringement exposure concentrated? Which competitors hold patents in overlapping technology spaces? Which patent families create correlated risk? A single risky patent is an FTO problem. A cluster of risky patents across a product line is a portfolio intelligence problem.

A single FTO addresses the first dimension. A structured de-risking program addresses all four, continuously.

Six requirements for structured patent de-risking

If patent infringement avoidance is an intelligence problem, the requirements follow from the intelligence — not from the legal filings. Six capabilities stand out.

1Claim-level risk mapping

Before a product launches — and periodically thereafter — the relevant patent landscape needs to be mapped at the claim level, not the patent level. A patent with twenty claims may have seventeen that are irrelevant and three that create genuine exposure. The mapping must identify which specific claims create risk, and which elements of those claims are the exposure points.

This is where element-by-element claim charting becomes essential. For each claim of interest, each limitation is mapped to a specific feature of the product. A limitation that cannot be mapped is a gap in the infringement theory — and a gap is the starting point for a design-around.

Patent-level risk assessments — "this patent is relevant" — are too coarse to support design-around decisions. Claim-level mapping is the minimum resolution at which avoidance becomes actionable.

2Prosecution-history-informed scope analysis

The face of the claims tells you what the patent says. The prosecution history tells you what the patent means — and what the patentee gave up to get it.

Under Warner-Jenkinson, any unexplained amendment during prosecution creates a rebuttable presumption that the amendment was made for a reason relating to patentability.^[7]7Warner-Jenkinson Co. v. Hilton Davis Chemical Co., 520 U.S. 17, 33 (1997) (holding that any unexplained amendment creates a rebuttable presumption that it was made for a reason related to patentability). Under Festo, a narrowing amendment for patentability-related reasons triggers the presumption of surrender — rebuttable only on three grounds: the equivalent was unforeseeable at the time of the amendment, the rationale for the amendment bore no more than a tangential relation to the equivalent, or there is some other reason the patentee could not reasonably have been expected to describe the equivalent.^[8]8Festo, 535 U.S. at 740–41 (specifying unforeseeability, tangential relation, and "some other reason" as the three grounds for rebutting the presumption of surrender).

These doctrines mean that prosecution history is not supplementary context in infringement avoidance. It is the primary map of the patent's enforceable scope. Every narrowing amendment, every examiner argument that the applicant accepted or distinguished, every prior art reference that shaped the final claim language — all of these constrain the scope of the patent in ways that are invisible on the face of the issued claims.

An FTO that ignores prosecution history is reading the wrong map.

3Element-by-element design-around engineering

When a claim creates genuine risk, the most effective avoidance strategy is often a design-around: modifying the product so that it does not practice at least one limitation of the claim. Under patent law, a product that omits even a single element of a claim does not literally infringe. Omission — not substitution — is the cleanest path.

But omission is not always technically feasible. When the design-around relies on substituting one element for another, the substitute must survive analysis under the doctrine of equivalents. The question is whether the substitute performs substantially the same function, in substantially the same way, to achieve substantially the same result — and whether prosecution history estoppel bars the patentee from capturing the substitute as an equivalent.^[5]5Graver Tank & Mfg. Co. v. Linde Air Products Co., 339 U.S. 605 (1950) (establishing the doctrine of equivalents and the function-way-result test).

Effective design-arounds therefore require collaboration between engineers and patent counsel. Engineers identify technically feasible alternatives. Counsel assesses whether those alternatives fall outside both the literal claim scope and the equivalents reach, with estoppel taken into account. Documentation of the design-around rationale — which claim element was targeted, what alternative was chosen, why the alternative is outside equivalents range — is itself valuable evidence if the patent is later asserted.

4Continuous patent surveillance

The patent landscape changes weekly. New applications publish every Thursday. Granted patents issue every Tuesday. Continuation applications can introduce claims drafted years after the original filing — and potentially targeted at a competitor's products that did not exist when the parent application was filed.

A structured de-risking program monitors the relevant technology space continuously: new publications, newly granted patents, newly asserted claims, and changes in patent ownership (assignments often signal licensing campaigns or litigation preparation). The monitoring should be keyed to CPC classification codes, assignee names, and specific claim language patterns — and it should trigger re-assessment of existing risk maps when a relevant patent issues.

This is the capability that converts de-risking from a point-in-time gate into a continuous intelligence function. Without it, every FTO opinion has a shelf life measured in months.

5Validity challenge readiness

Not every risky patent requires a design-around. Some should be challenged.

Inter partes review at the PTAB provides a powerful mechanism for challenging patent validity. IPR proceedings are faster than district court litigation — the PTAB is statutorily required to issue a final written decision within twelve months of institution — and substantially cheaper. Through 2024, approximately 70% of all challenged claims were invalidated in final written decisions.^[6]6IPWatchdog, "The PTAB's 70% All-Claims Invalidation Rate Continues to Be a Source of Concern" (Jan. 2025). Available at ipwatchdog.com.

In Europe, EPO opposition proceedings offer a similarly effective route. Roughly one-third of opposed European patents are revoked in full and another third forced into meaningful amendment — a combined rate of approximately 70% revocation or narrowing.^[9]9EPO opposition-division outcomes, five-year average. Roughly one-third of opposed European patents are revoked in full and another third amended — a combined rate of approximately 70% revocation or meaningful narrowing. See Oxon IP, "EPO Opposition Statistics: A Five-Year Review." Available at oxonip.com. Under the Unified Patent Court, a well-timed EPO opposition has become a key defensive tool in preliminary injunction proceedings.

Validity challenge readiness means identifying strong prior art references before litigation arrives: maintaining claim charts that map prior art to claim elements, tracking which patents in the risk landscape are vulnerable to challenge, and understanding the estoppel consequences of each challenge pathway so the decision to file is informed rather than reactive.

6Portfolio-level strategy and proactive licensing

Some patent risk is best managed not by avoidance or challenge but by negotiation. Proactive licensing — approaching a patent holder before a dispute crystallizes — can be dramatically less expensive than litigating after a complaint is filed. When the alternative is millions in litigation costs, a reasonable royalty negotiated early is often the rational economic choice.

Portfolio-level strategy also includes building defensive patent assets. A company with its own patents in overlapping technology spaces has negotiating leverage — cross-licensing, counter-assertion, mutual deterrence — that a company without patents does not. Patent pools, defensive publishing, and open patent pledges are additional tools that reduce infringement exposure across the product line rather than for a single product.

Research confirms that the effects of patent risk extend beyond legal costs: firms targeted by NPE litigation shift their innovation strategies — drawing more heavily on in-house technologies and reducing reliance on external knowledge — to shrink the legal attack surface for future suits.^[10]10Kenneth G. Huang, Mei-Xuan Li, Carl Hsin-han Shen & Yanzhi Wang, "Escaping the Patent Trolls: The Impact of Non-Practicing Entity Litigation on Firm Innovation Strategies," Strategic Management Journal (2024). Available at doi.org/10.1002/smj.3606. That strategic distortion is itself a cost of reactive risk management, and one that a structured de-risking program can mitigate.

The prosecution record is the de-risking signal most teams ignore

Of the six capabilities above, prosecution-history-informed scope analysis is the one most consistently absent from corporate de-risking programs. It is also the one that most directly determines whether the other five will work.

Claim-level risk mapping is only as good as the scope assessment that underlies it. If the scope is wrong — if the claims are read too broadly because prosecution estoppel was missed, or too narrowly because a limiting argument in the file wrapper was overlooked — the risk map is wrong. Every downstream decision built on it is wrong: the design-around targets the wrong element, the validity challenge attacks the wrong claim, the licensing negotiation uses the wrong denominator.

Design-arounds succeed or fail on whether the substitute element falls outside the equivalents range. Prosecution history estoppel is the single most reliable doctrinal basis for establishing that it does. A design-around strategy that does not start with the prosecution record is navigating without a map.

Validity challenges are strongest when the prior art was already cited or distinguished during prosecution. The prosecution record reveals exactly what the examiner considered, exactly what the applicant argued to overcome it, and exactly where the gaps in the prior art analysis remain. Prior art that the examiner never saw is more potent under §325(d) than art that was already considered and distinguished.

And proactive licensing negotiations benefit from understanding the actual enforceable scope of the licensed patents. A license at three percent royalty may be reasonable for a patent with broad, unamended claims surviving a clean prosecution. It makes far less economic sense for a patent narrowed through three rounds of rejection and response to cover a specific embodiment that the licensee's product may not even practice.

The prosecution record is not one data source among many in the avoidance workflow. It is the foundation that every other layer depends on. Yet most de-risking programs — even sophisticated ones run by large in-house IP teams — treat prosecution history as something to review when litigation arrives, not as structured intelligence to be captured and maintained in advance.

What becomes possible when de-risking is structured

None of the capabilities below require novel legal doctrine. They require treating patent risk as a structured data problem — one where the prosecution record is the primary input, not an afterthought.

A company with structured, claim-level patent intelligence can answer questions that most IP teams today cannot:

Which products carry the highest infringement exposure, and where specifically does that exposure concentrate? Not at the patent level — at the claim-element level, with prosecution-history-informed scope analysis attached. The difference between "we have exposure to Patent X" and "we have exposure to claim 3 of Patent X, but the patentee surrendered equivalents coverage for element (c) during a §103 narrowing amendment in the second office action response" is the difference between anxiety and an actionable risk assessment.

Which risk patents are most vulnerable to validity challenge? With claim charts against prior art maintained continuously rather than assembled under litigation deadline, the decision to file an IPR or EPO opposition can be made strategically — before a complaint is served — rather than reactively, after a demand letter has already compressed the timeline.

Where in the product roadmap should design-arounds be prioritized? With the investment in each design-around calibrated to the actual enforceable scope of the risk patent, not a worst-case reading of the issued claims. Some design-arounds are unnecessary once prosecution estoppel is accounted for. Others are more urgent than they appear from the claim text alone.

What is the patent risk profile of a target company's product line? For M&A due diligence, structured claim intelligence means an acquiring company can assess infringement exposure quantitatively — not from a law firm's qualitative opinion delivered in the eleventh hour of a deal, but from a continuously maintained risk map that the target's IP team has been building all along.

These are not speculative capabilities. They are what becomes straightforward when patent de-risking is treated as a structured intelligence problem rather than a series of one-off legal opinions.

A note on where we are

The argument in this post is not unique to Contist — any IP team that takes prosecution history seriously as structured data, rather than a box of PDFs to be opened under deadline, will reach similar conclusions about what de-risking should look like.

Contist is where we are building toward that architecture: claim-level intelligence grounded in structured prosecution history, not just claim text, as the foundation for de-risking, infringement analysis, and portfolio analytics. If your team is managing patent risk across a portfolio and the current workflow depends on point-in-time FTO searches and institutional memory, we would like to hear from you.

Contist AI is building a patent prosecution platform focused on structured prosecution history, claim-level infringement analysis, and portfolio analytics. The founder previously worked on document intelligence at Securiti.ai and holds a Ph.D. and M.S. in Mathematics and an M.S. in Computer Science.

Reach Contist at sales@contist.ai · Follow on LinkedIn.